301 related articles for article (PubMed ID: 8640754)
1. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder.
Peters MM; Rivera MI; Jones TW; Monks TJ; Lau SS
Cancer Res; 1996 Mar; 56(5):1006-11. PubMed ID: 8640754
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat.
Peters MM; Lau SS; Dulik D; Murphy D; van Ommen B; van Bladeren PJ; Monks TJ
Chem Res Toxicol; 1996; 9(1):133-9. PubMed ID: 8924582
[TBL] [Abstract][Full Text] [Related]
3. Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes.
Tajima K; Hashizaki M; Yamamoto K; Mizutani T
Drug Metab Dispos; 1991; 19(6):1028-33. PubMed ID: 1687007
[TBL] [Abstract][Full Text] [Related]
4. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
Monks TJ; Highet RJ; Lau SS
Mol Pharmacol; 1988 Oct; 34(4):492-500. PubMed ID: 3173333
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone.
Peters MM; Jones TW; Monks TJ; Lau SS
Carcinogenesis; 1997 Dec; 18(12):2393-401. PubMed ID: 9450487
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney.
Rivera MI; Hinojosa LM; Hill BA; Lau SS; Monks TJ
Drug Metab Dispos; 1994; 22(4):503-10. PubMed ID: 7956722
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 2-(glutathion-S-yl)hydroquinone and 2,3,5- (triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity.
Hill BA; Davison KL; Dulik DM; Monks TJ; Lau SS
Toxicol Appl Pharmacol; 1994 Nov; 129(1):121-32. PubMed ID: 7974485
[TBL] [Abstract][Full Text] [Related]
8. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells.
Carvalho M; Hawksworth G; Milhazes N; Borges F; Monks TJ; Fernandes E; Carvalho F; Bastos ML
Arch Toxicol; 2002 Oct; 76(10):581-8. PubMed ID: 12373454
[TBL] [Abstract][Full Text] [Related]
9. Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
Jeong JK; Stevens JL; Lau SS; Monks TJ
Mol Pharmacol; 1996 Sep; 50(3):592-8. PubMed ID: 8794898
[TBL] [Abstract][Full Text] [Related]
10. Modulation of quinol/quinone-thioether toxicity by intramolecular detoxication.
Monks TJ
Drug Metab Rev; 1995; 27(1-2):93-106. PubMed ID: 7641587
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gamma-glutamyl transpeptidase potentiates the nephrotoxicity of glutathione-conjugated chlorohydroquinones.
Mertens JJ; Temmink JH; van Bladeren PJ; Jones TW; Lo HH; Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1991 Aug; 110(1):45-60. PubMed ID: 1678558
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes.
Cummings SW; Ansari GA; Guengerich FP; Crouch LS; Prough RA
Cancer Res; 1985 Nov; 45(11 Pt 2):5617-24. PubMed ID: 4053035
[TBL] [Abstract][Full Text] [Related]
13. The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition.
Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1990 Mar; 103(1):121-32. PubMed ID: 1969181
[TBL] [Abstract][Full Text] [Related]
14. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy.
Hill BA; Kleiner HE; Ryan EA; Dulik DM; Monks TJ; Lau SS
Chem Res Toxicol; 1993; 6(4):459-69. PubMed ID: 8374043
[TBL] [Abstract][Full Text] [Related]
15. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
Lau SS; Kleiner HE; Monks TJ
Drug Metab Dispos; 1995 Oct; 23(10):1136-42. PubMed ID: 8654203
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of t-Butylhydroquinone (CAS No. 1948-33-0) in F344/N Rats and B6C3F(1) Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 459():1-326. PubMed ID: 12587017
[TBL] [Abstract][Full Text] [Related]
17. Estimated daily intakes of butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-butyl hydroquinone (TBHQ) antioxidants in Korea.
Suh HJ; Chung MS; Cho YH; Kim JW; Kim DH; Han KW; Kim CJ
Food Addit Contam; 2005 Dec; 22(12):1176-88. PubMed ID: 16356880
[TBL] [Abstract][Full Text] [Related]
18. The effect of oxygen tension on the cytotoxicity of hydroquinone and selected hydroquinone metabolites to isolated rat renal proximal tubular cells.
Boatman RJ; English JC; Guerin TS; Cummings LM
Arch Toxicol; 2004 Aug; 78(8):443-52. PubMed ID: 15083269
[TBL] [Abstract][Full Text] [Related]
19. DNA damage, gadd153 expression, and cytotoxicity in plateau-phase renal proximal tubular epithelial cells treated with a quinol thioether.
Jeong JK; Dybing E; Søderlund E; Brunborg G; Holme JA; Lau SS; Monks TJ
Arch Biochem Biophys; 1997 May; 341(2):300-8. PubMed ID: 9169019
[TBL] [Abstract][Full Text] [Related]
20. Developmental toxicity of bromohydroquinone (BHQ) and BHQ-glutathione conjugates in vivo and in whole embryo culture.
Andrews JE; Rogers JM; Ebron-McCoy M; Logsdon TR; Monks TJ; Lau SS
Toxicol Appl Pharmacol; 1993 May; 120(1):1-7. PubMed ID: 8099763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
